CytoDyn (CYDY) Interest Coverage Ratio (QoQ) (2010 - 2026)
CytoDyn (CYDY) Interest Coverage Ratio (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | CytoDyn | 258.01 Mn | 258.01 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 38.59% |
| Nov 30, 2025 | -251.12% |
| Aug 31, 2025 | -762.94% |
| May 31, 2025 | 94.61% |
| Feb 28, 2025 | -9.69% |
| Nov 30, 2024 | -116.58% |
| Aug 31, 2024 | 16,470.05% |
| May 31, 2024 | 96.03% |
| Feb 29, 2024 | -1.61% |
| Nov 30, 2023 | 24.23% |
| Aug 31, 2023 | -2,584.35% |
| May 31, 2023 | 138.69% |
| Feb 28, 2023 | 94.23% |
| Nov 30, 2022 | -707.33% |
| Aug 31, 2022 | 94.17% |
| May 31, 2022 | -1,566.03% |
| Feb 28, 2022 | 48.36% |
| Nov 30, 2021 | -87.98% |
| Aug 31, 2021 | -79.36% |
| May 31, 2021 | 88.76% |